AHIP CEO: “We Are Laser-Focused on Affordability”
Rising healthcare costs are a key focus for AHIP, whose CEO says the group is pushing reforms to boost competition and reduce administrative burden.
Virtual Specialty Care Has Time. Will We Use It Wisely?
The specialty access and capacity crisis demands more than incremental fixes. It requires expanding virtual access and fundamentally rethinking how specialty care can be delivered.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage
In a recent letter, Senate Democrats proposed lowering healthcare costs, expanding coverage and cracking down on insurance company practices.
NYU Stern Report Urges Regulation of Private Equity in Healthcare
An NYU Stern report links private equity in healthcare to worse outcomes and higher bankruptcy risk, calling for reforms and stronger oversight.
A Once in a Generation Opportunity to Reimagine Rural Health
Leaders must resist the urge to replicate urban models that do not translate well to rural contexts. Instead, they should design solutions that are built for rural communities, grounded in local insight and enabled by scalable capabilities.
Behavior Changes Happen Outside the Exam Room, But Validation of Lifestyle Medicine Programs Cannot
If CMS and private payers are serious about whole-person health, reimbursement structures must align with the workforce actually delivering that care. Payment pathways should recognize the value of the broader care team and enable the seamless integration of their expertise with the objective data generated through connected devices and programs like RPM.
How Artera is Using Agentic AI to Humanize Patient Care
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
Why The Epic-Health Gorilla Case Just Got Juicier
GuardDog Telehealth admitted it misrepresented its services to access patients’ health information, marking the first major concession in Epic’s lawsuit against Health Gorilla and other defendants accused of exploiting interoperability networks. The broader case is still ongoing.
Employer Groups Applaud Bill that Aims to Spur Competition in Healthcare
Employer groups praised a bill aimed at boosting healthcare competition and lowering costs by banning anticompetitive insurer-provider contracts.
Real-World Evidence Meets Machine Learning: What It Takes to Future-Proof Evidence Generation
Every life sciences organization needs to consider how best to apply machine learning (ML) to RWE to support better patient outcomes. Here’s how they can ensure RWE is “ML-ready.”
The Lethal Cost of Regulatory Perfection in Rare Disease
Congress has already granted the FDA flexibility in evaluating therapies for rare diseases, including the use of real-world evidence and natural history data when traditional large-scale trials are not feasible. The question before the FDA now is not if those tools can be applied – they can – but if the agency has the courage to use them before more patients lose their autonomy, and ultimately, their lives, to rare disease.
The Mechanics of a More Connected Healthcare Ecosystem [Video]
Arbiter’s Anjali Jameson on hospital and payer alignment.
Debunked Episode 24: PBM Reform Brainstorm, Elevance Faces CMS Penalty Risk, Hims & Hers’ Eucalyptus Deal Takeaways
In the latest episode of the Debunked Podcast, the discussion revolved around the Break Up Big Medicine legislation to rein in healthcare giants and ways to introduce meaningful PBM reform.
It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?
Experts say the bipartisan Break Up Big Medicine Act — aimed at breaking up vertically integrated healthcare companies — faces slim chances of passing despite recent PBM reforms.
presented by
Using Real World Data from the Patient Experience to Improve Drug Development
A new eBook published by MedCity News for PurpleLab highlights how RWD and SDOH can lead to more inclusive clinical trials and drugs that improve the quality of life for larger, diverse patient populations not only for NSCLC, but other conditions as well.
Why Trump’s ‘Cash for Healthcare’ Idea Likely Wouldn’t Work in Practice
Last week, Trump proposed cutting out insurers and giving Americans cash to buy their own healthcare, claiming it would lower costs. Ali Diab, an economist and CEO of Collective Health, said the plan overlooks the real problem: concentrated payer power, opaque pricing and the financial risk people face without insurance.
How New Medicare Rules Will Reshape Cardiac Monitoring and Remote Patient Care
For providers, the rules mean more control over monitoring and the chance to keep a larger share of reimbursement. For device companies, they create a chance to show measurable value and guide clinicians through a system that is shifting quickly.